INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses to Contact the Firm Pharmaceutical Investing
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Pharmaceutical Investing
AbbVie Announces ABBV-951 Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's Disease Pharmaceutical Investing
HempFusion Launches Ingestible and Topical CBD Products into Major Arizona Grocer Cannabis Investing News
SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HEPS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of APPH, BMY, EAR and HNST Pharmaceutical Investing
